Use access key #2 to skip to page content.
$22.23 1.13 (5.36%)
11/21/2008 4:00 PM

Invitrogen Corp (IVGN)

CAPS Rating:
****

A developer, manufacturer and marketer of research tools in reagent, kit and high-throughput applications forms to customers engaged in life sciences research, drug discovery, diagnostics and the commercial manufacture of biological products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating IVGN

Add Stock to Watchlist

What the Community Thinks

Total Members

184 Outperforms
19 Underperforms
 

All-Stars

47 Outperforms
8 Underperforms
 

Wall Street

9 Outperforms
0 Underperforms
 

Members bullish on IVGN are also bullish on:

Members bearish on IVGN are also bearish on:

Ticker Tags

Life Sciences Tools and Services (59), California (41), Small Cap (1354), San Diego (15)
Suggest a tag

Invitrogen Corp At A Glance

Current Price: $22.23
Last Trade Time: 11/21/2008 4:00 PM
Open: $21.70
Previous Close: $21.10
Daily Range: $19.56 - $22.41
52-Week Range: $20.28 - $49.58
Volume: 24,739,175
Market Cap: $1.95B
P/E Ratio: 10.99
Compare Our Special Broker Offers!

Stock Trends

IVGN VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for IVGN

More Headlines...

Top Bull Pitch

Recs

3

Invitrogen Corp (IVGN)

Avatar Vet67to82 (98.92) Submitted: 10/15/08 2:06 PM

2008 Q3 Possible earning surprise to the upside.
Analyst(s) Mean Estimate: $0.58 Possible surprise .....$0.60

Yeah, it's only 2 additional cents more .....but Wall Street loves that !!

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 37 :   1 2 3 4 5 Next »

Recs

0

 (IVGN)

Avatar TMFHelical (99.37) Submitted: 11/20/08 9:26 PM : Outperform Start Price: $21.70 IVGN Score: 4.11

There is a lot to not like about this company. Past serial acquisition ways crashed them once before, but for a while it looked like they were finally focused on getting the whole act together. Then they go and merge with ABI. Yes the combined company is better IMO, but here we go again.

Still $21? 1.5X sales. That is just nuts for a company whose products absolutely everyone in biotech purchases. Buy it now, but don't be shy to when it shows strength again.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (IVGN)

Avatar jmt587 (99.89) Submitted: 11/04/08 4:36 PM : Underperform Start Price: $28.83 IVGN Score: -0.68

Research tools. No dividend, high P/E.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (IVGN)

Avatar jajex1 (93.46) Submitted: 10/23/08 9:43 AM : Outperform Start Price: $29.15 IVGN Score: -9.48

tdrh pick. Solid looking company

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (IVGN)

Avatar TDRH (99.99) Submitted: 10/22/08 8:23 AM : Outperform Start Price: $29.75 IVGN Score: -6.60

Stolen from MACE60

Report this Post Replies: 0 | Reply | Permalink

Recs

3

 (IVGN)

Avatar Vet67to82 (98.92) Submitted: 10/15/08 2:06 PM : Outperform Start Price: $29.42 IVGN Score: -3.56

2008 Q3 Possible earning surprise to the upside.
Analyst(s) Mean Estimate: $0.58 Possible surprise .....$0.60

Yeah, it's only 2 additional cents more .....but Wall Street loves that !!

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 37 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 9 of 9  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackUBS 85.75 10/21/08 Outperform NS $31.00-28.29%-21.81%-6.48
TrackCowenandCo 78.45 09/23/08 Outperform NS $38.60-42.41%-37.21%-5.20
TrackJPMorgan < 20 06/24/08 Outperform NS $40.45-45.04%-42.19%-2.86
TrackFirstAnalys 98.01 06/13/08 Outperform NS $39.21-43.31%-44.18%+0.87
TrackDeutscheSec < 20 02/06/08 Outperform NS $44.47-50.02%-43.24%-6.78
TrackSoros < 20 09/30/07 Outperform NS $40.87-45.60%-50.30%+4.70 Toggle the visibility of 60-Second Pitch and replies
TrackAmTechJSA 53.72 02/14/07 Outperform NS $32.67-31.96%-47.92%+15.96
TrackBofASec 95.85 10/27/06 Outperform NS $28.59-22.25%-45.28%+23.03
TrackScottBleier 75.69 10/06/06 Outperform 3M $31.83-30.15%-43.81%+13.66

Results 1 - 9 of 9  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links